The Effects of Weight Reduction With Orlistat vs. Placebo on Changes in Body Composition.
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2013
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity; Overweight
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 06 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2011 Results presented at the 2011 Annual Meeting of the North American Association for the Study of Obesity.
- 30 Jun 2011 Results published in Obesity
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History